November 30, 2015 FDA approves new Bristol-Myers treatment for multiple myeloma The U.S. Food and Drug Administration said on Monday it had approved a drug to be sold by Bristol-Myers Squibb Co as a treatment for a form of blood cancer.
November 27, 2015 Gene test can help recommend best psychiatric medications for patients Psychiatrists can use a simple genetic test to determine which psychoactive medications will be most easily metabolized by their patients. And a third clinical study has confirmed that this test has a positive effect on treatment outcome.
November 27, 2015 A newer beta blocker may be less of a psychiatric scourge A new beta blocker marketed as Bystolic (generic name, nebivolol) is available that may be the answer for many patients suffering from heart arrhythmia and hypertension.
November 27, 2015 Deplin: A 'medical food' that treats depression Deplin, a derivative of folate (vitamin B9), is proving to be a powerful weapon in the treatment of depression.
November 27, 2015 Turing reneges on drug price cut, rival's version sells well After weeks of criticism from patients, doctors and other drugmakers for hiking a life-saving medicine's price more than fifty-fold, Turing Pharmaceuticals is reneging on its pledge to cut the $750-per-pill price.
November 25, 2015 Pfizer's Lyrica shows no relief from post-traumatic nerve pain Pfizer Inc said its blockbuster pain drug, Lyrica, had failed to show benefit in patients suffering from a type of post-traumatic nerve pain, in a late-stage study.
November 25, 2015 Company at center of drug pricing storm cuts cost of medicine Turing Pharmaceuticals, the company that became a lightning rod for criticism over excessive price increases for older medicines, on Tuesday said it would cut the cost of its anti-infection drug to hospitals.
November 24, 2015 Off-label drug uses increases risk of negative side effects, study says About 12 percent of drugs doctors prescribe are for uses other than those approved by regulators, a recent study found.
November 24, 2015 Expensive new Hep C drugs may be cost-effective even for early disease Treating hepatitis C with expensive new medicines at the earliest signs of liver damage improves patients' health and is also cost-effective, a new computer simulation suggests.
November 24, 2015 Docs, and patients, should remember to use generics Prescribing generic medicines instead of brand name drugs whenever possible cuts costs, improves patient adherence and improves health outcomes, according to a new recommendation from the American College of Physicians.
